Policy

Evidence Development

Background

The future of personalized medicine depends in part on the development of evidence to demonstrate the field's clinical and economic value.

In July of 2017, PMC supported a draft bill from Rep. Eric Swalwell (D-CA) that would provide for a study at the National Academy of Medicine (NAM) on the use of genetic and genomic testing to improve health care outcomes.

2017

"Access to Precision Medicine Advancement Act"